Literature DB >> 23975570

Rapid-acquisition myocardial perfusion scintigraphy (MPS) on a novel gamma camera using multipinhole collimation and miniaturized cadmium-zinc-telluride (CZT) detectors: prognostic value and diagnostic accuracy in a 'real-world' nuclear cardiology service.

F U Chowdhury1, S Vaidyanathan, M Bould, J Marsh, C Trickett, K Dodds, T P R Clark, R J Sapsford, C J Dickinson, C N Patel, P J Thorley.   

Abstract

AIMS: To study the prognostic value of rapid-acquisition adenosine stress-rest myocardial perfusion scintigraphy (MPS) on a gamma camera using multipinhole collimation and cadmium-zinc-telluride (CZT) detectors. The secondary aim was to assess the diagnostic accuracy of the technique compared with invasive coronary angiography. METHODS AND
RESULTS: Retrospective analysis of 1109 consecutive patients undergoing MPS in a routine clinical setting on a high-efficiency multipinhole gamma camera. MPS acquisition, performed with a standard injection of 550 MBq of (99m)Tc-tetrofosmin, required a mean (±SD) scanning time of 322 ± 51 s. The hard cardiac event rate at a median (inter-quartile range) follow-up of 624 (552-699) days was 0.4% (95% CI 0.1-1.1) in patients with no significant perfusion abnormality versus 6.8% (95% CI 4.3-10.7%, P < 0.001) in those with an abnormal scan. In a sub-group of 165 patients, comparison with obstructive coronary artery disease on X-ray angiography gave a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for rapid-acquisition MPS of 84% (95% CI 74-91), 79% (95% CI 68-87), 82% (95% CI 72-89), 81% (95% CI 70-89), and 82% (95% CI 73-89), respectively.
CONCLUSIONS: MPS performed on a CZT solid-state detector camera with multipinhole collimation is an evolutionary development that provides reliable prognostic and diagnostic information, while significantly reducing image acquisition time.

Entities:  

Keywords:  cadmium–zinc–telluride; coronary artery disease; high efficiency; multipinhole collimation; myocardial perfusion scintigraphy

Mesh:

Substances:

Year:  2013        PMID: 23975570     DOI: 10.1093/ehjci/jet149

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  10 in total

1.  Prognostic value of normal stress-only myocardial perfusion imaging: a comparison between conventional and CZT-based SPECT.

Authors:  Shu Yokota; Mohamed Mouden; Jan Paul Ottervanger; Elsemiek Engbers; Siert Knollema; Jorik R Timmer; Pieter L Jager
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-21       Impact factor: 9.236

2.  Effect of a patient-specific minimum activity in stress myocardial perfusion imaging using CZT-SPECT: Prognostic value, radiation dose, and scan outcome.

Authors:  J D van Dijk; N M Borren; M Mouden; J A van Dalen; J P Ottervanger; P L Jager
Journal:  J Nucl Cardiol       Date:  2017-08-18       Impact factor: 5.952

3.  Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.

Authors:  Viviany R Taqueti; Sharmila Dorbala; David Wolinsky; Brian Abbott; Gary V Heller; Timothy M Bateman; Jennifer H Mieres; Lawrence M Phillips; Nanette K Wenger; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2017-06-05       Impact factor: 5.952

4.  Prognostic value of combined coronary angiography-derived IMR and myocardial perfusion imaging by CZT SPECT in INOCA.

Authors:  Lu Liu; Neng Dai; Guoqing Yin; Wen Zhang; Abdul-Quddus Mohammed; Siling Xu; Xian Lv; Tingting Shi; Cailin Feng; Ayman A Mohammed; Redhwan M Mareai; Yawei Xu; Xuejing Yu; Fuad A Abdu; Fei Yu; Wenliang Che
Journal:  J Nucl Cardiol       Date:  2022-08-02       Impact factor: 3.872

5.  A preliminary feasibility study of simultaneous dual-isotope imaging with a solid-state dedicated cardiac camera for evaluating myocardial perfusion and fatty acid metabolism.

Authors:  Toshiyuki Ko; Yuko Utanohara; Yasuhiro Suzuki; Makiko Kurihara; Nobuo Iguchi; Jun Umemura; Tetsuya Sumiyoshi; Hitonobu Tomoike
Journal:  Heart Vessels       Date:  2014-09-13       Impact factor: 2.037

Review 6.  Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM).

Authors:  Denis Agostini; Pierre-Yves Marie; Simona Ben-Haim; François Rouzet; Bernard Songy; Alessandro Giordano; Alessia Gimelli; Fabien Hyafil; Roberto Sciagrà; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-19       Impact factor: 9.236

7.  Diagnostic performance of myocardial perfusion imaging with conventional and CZT single-photon emission computed tomography in detecting coronary artery disease: A meta-analysis.

Authors:  Valeria Cantoni; Roberta Green; Wanda Acampa; Emilia Zampella; Roberta Assante; Carmela Nappi; Valeria Gaudieri; Teresa Mannarino; Renato Cuocolo; Eugenio Di Vaia; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2019-05-14       Impact factor: 5.952

8.  Value of attenuation correction in stress-only myocardial perfusion imaging using CZT-SPECT.

Authors:  J D van Dijk; M Mouden; J P Ottervanger; J A van Dalen; S Knollema; C H Slump; P L Jager
Journal:  J Nucl Cardiol       Date:  2016-01-15       Impact factor: 5.952

Review 9.  Diagnostic value of cadmium-zinc-telluride myocardial perfusion imaging versus coronary angiography in coronary artery disease: A PRISMA-compliant meta-analysis.

Authors:  Yi-Qing Zhang; Yu-Feng Jiang; Lu Hong; Min Chen; Nan-Nan Zhang; Hua-Jia Yang; Ya-Feng Zhou
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

10.  Incremental Diagnostic Performance of Combined Parameters in the Detection of Severe Coronary Artery Disease Using Exercise Gated Myocardial Perfusion Imaging.

Authors:  Chia-Ju Liu; Yen-Wen Wu; Kuan-Yin Ko; Yi-Chieh Chen; Mei-Fang Cheng; Ruoh-Fang Yen; Kai-Yuan Tzen
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.